Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on International Tech Times.
Press releases published on March 20, 2025
VYNE Therapeutics to Participate in the H.C. Wainwright 3rd Annual Autoimmune & Inflammatory Disease Virtual Conference
GlobeNewswire
·
March 20, 2025
BRIDGEWATER, N.J., March 20, 2025 (GLOBE NEWSWIRE) -- VYNE Therapeutics Inc. (Nasdaq: VYNE) (“VYNE” or the “Company”), a clinical-stage biopharmaceutical company focused on developing differentiated therapies to treat chronic inflammatory and immune …
Reflect Scientific Inc. Reports Strong Revenue Growth in 2024
GlobeNewswire
·
March 20, 2025
OREM, Utah, March 20, 2025 (GLOBE NEWSWIRE) -- Reflect Scientific, Inc. (OTC: RSCF), a leading provider of cryogenic cooling and laboratory equipment, is pleased to announce a significant increase in revenue for the fiscal year ending December 31, 2024. …
NevGold Increases the Size of the Zeus Copper Project by Approximately 50% Or 1,000 Hectares in the Hercules Copper District, Idaho
GlobeNewswire
·
March 20, 2025
Vancouver, British Columbia, March 20, 2025 (GLOBE NEWSWIRE) -- NevGold Corp. (“NevGold” or the “Company”) (TSXV:NAU) (OTCQX:NAUFF) (Frankfurt:5E50) is pleased to announce that it has staked an additional 147 claims, approximately 1,000 hectares or 10 …
Immutep to Present Pivotal TACTI-004 Trial in Progress Poster at the European Lung Cancer Congress 2025
GlobeNewswire
·
March 20, 2025
SYDNEY, AUSTRALIA, March 20, 2025 (GLOBE NEWSWIRE) -- Immutep Limited (ASX: IMM; NASDAQ: IMMP) (“Immutep” or “the Company”), a late-stage immunotherapy company targeting cancer and autoimmune diseases, today announces an upcoming poster presentation for …
Candel Therapeutics and IDEA Pharma Announce Strategic Partnership to Advance Path-to-Market Commercialization Efforts for CAN-2409
GlobeNewswire
·
March 20, 2025
NEEDHAM, Mass., March 20, 2025 (GLOBE NEWSWIRE) -- Candel Therapeutics, Inc. (Candel or the Company) (Nasdaq: CADL), a clinical stage biopharmaceutical company focused on developing multimodal biological immunotherapies to help patients fight cancer, …
Founder Group Secures Contract Valued at US$2.6 Million to Build a Roof-Top Solar Generating Facility in Malaysia
GlobeNewswire
·
March 20, 2025
KUALA LUMPUR, Malaysia, March 20, 2025 (GLOBE NEWSWIRE) -- Founder Group Limited (NASDAQ: FGL) (“Founder Group” or the “Company”), a leading engineering, procurement, construction, and commissioning (EPCC) solutions provider for solar photovoltaic (PV) …
Windtree Announces License and Supply Agreement to Become Sourcing Partner for a Small Biotech with an FDA Approved Product
GlobeNewswire
·
March 20, 2025
WARRINGTON, Pa., March 20, 2025 (GLOBE NEWSWIRE) -- Windtree Therapeutics, Inc. (“Windtree” or the “Company”) (NasdaqCM: WINT), a biotechnology company focused on becoming a revenue generating biotech and advancing early and late-stage innovative therapies …
Pathos AI Doses First Patient in Phase 1b/2a Clinical Trial of Pocenbrodib, a CBP/p300 Inhibitor
GlobeNewswire
·
March 20, 2025
CHICAGO, March 20, 2025 (GLOBE NEWSWIRE) -- Pathos AI, (www.pathos.com), a clinical-stage biotechnology company focused on re-engineering drug development through artificial intelligence, announced the first patient has been dosed in the Company’s Phase 1b …
REPEAT: Rocket Doctor Scales Rapidly in Alberta, Strengthening Physician Independence and Expanding Healthcare Access
GlobeNewswire
·
March 20, 2025
●71,000+ Albertans have received care through Rocket Doctor, with 35% of patients residing in communities with populations under 25,000. ●A 112% increase in patient visits between 2023 and 2024, demonstrating strong demand for online healthcare solutions. …
Indaptus Therapeutics Reports New Data Demonstrating Successful Broad Immune System Activation in Weekly Dosing Trial of Decoy20
GlobeNewswire
·
March 20, 2025
NEW YORK, March 20, 2025 (GLOBE NEWSWIRE) -- Indaptus Therapeutics, Inc. (Nasdaq: INDP), a clinical-stage biotechnology company dedicated to developing novel treatments for cancer and viral infections, today provided an update on key pharmacodynamic …
PubMatic’s Connect Platform for Curation Delivers for Publishers: Drives 25%+ Higher eCPMs, Incremental Revenue and Diverse Demand
GlobeNewswire
·
March 20, 2025
NO-HEADQUARTERS/REDWOOD CITY, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- PubMatic, an independent technology company delivering digital advertising’s supply chain of the future, today announces the success and impact of its Connect platform in driving …
AI-powered Chemical Manufacturing Market to Expand at 28.8% CAGR, Generating US$ 37.6 Billion by 2034 as Industry Embraces Smart Technologies | Latest Report by Transparency Market Research
GlobeNewswire
·
March 20, 2025
Wilmington, Delaware, Transparency Market Research, Inc. –, March 20, 2025 (GLOBE NEWSWIRE) -- The future of the chemical industry is being reshaped by artificial intelligence, driving unprecedented efficiency and innovation. The AI-based Chemical …
Vitamin K2 Market to Reach US$ 1,160.78 Million by 2030, Growing at a CAGR of 29.7%, Says The Insight Partners
GlobeNewswire
·
March 20, 2025
US …
Creative Medical Technology Holdings Secures FDA Clearance for Expanded Dose Escalation in the Clinical Trial of CELZ-201-DDT for Chronic Lower Back Pain
GlobeNewswire
·
March 20, 2025
PHOENIX, March 20, 2025 (GLOBE NEWSWIRE) -- Creative Medical Technology Holdings, Inc. (NASDAQ: CELZ) (the “Company”), a clinical-stage biotechnology company specializing in regenerative medicine, today announced that the U.S. Food and Drug Administration …
Alarum Technologies Announces Fourth Quarter and Annual 2024 Results
GlobeNewswire
·
March 20, 2025
A Pivotal Year, Marking Accomplishment of Strategic Shift to Data Collection, Hits Milestones Toward Becoming a Driving Force in the AI Revolution 2024 revenue increased to $31.8 million, of which $7.4 million was in the fourth quarter; 2024 net profit …
Duke Robotics Reports 2024 Financial Results and Provides Business Update
GlobeNewswire
·
March 20, 2025
FORT LAUDERDALE, FL, March 20, 2025 (GLOBE NEWSWIRE) -- Duke Robotics Corp. (OTCQB: DUKR) ("Duke Robotics" or the "Company"), a leader in advanced robotics technology and autonomous drone solutions, today reported financial results for the fourth quarter …
Plus Therapeutics Introduces REYOBIQ™, FDA-Accepted Proprietary Name for Lead Drug Candidate
GlobeNewswire
·
March 20, 2025
REYOBIQ™ (rhenium Re186 obisbemeda) continues to be under clinical investigation for Leptomeningeal Metastases (LM) and Recurrent Glioblastoma (GBM) HOUSTON, March 20, 2025 (GLOBE NEWSWIRE) -- Plus Therapeutics, Inc. (Nasdaq: PSTV) (the “Company”), a …
Intravenous Equipment Market is Projected US$ 35,2670 Million, Expanding at 5.9% CAGR by 2035 | Fact.MR Analysis
GlobeNewswire
·
March 20, 2025
Rockville, MD, March 20, 2025 (GLOBE NEWSWIRE) -- According to Fact.MR, a market research and competitive intelligence provider, the global intravenous (IV) equipment market is estimated to reach a valuation of US$ 19,881 million in 2025 and is expected to …
XOMA Royalty Declares Quarterly Preferred Stock Dividends
GlobeNewswire
·
March 20, 2025
EMERYVILLE, Calif., March 20, 2025 (GLOBE NEWSWIRE) -- XOMA Royalty Corporation (Nasdaq: XOMA) today announced its Board of Directors has authorized the following cash dividends to holders of XOMA Royalty’s Series A and Series B Cumulative Preferred Stock: …
Revival Gold Enters Marketing Services Agreement
GlobeNewswire
·
March 20, 2025
TORONTO, March 20, 2025 (GLOBE NEWSWIRE) -- Revival Gold Inc. (TSXV: RVG, OTCQX: RVLGF) ("Revival Gold" or the "Company") is pleased to announce that the Company has entered into a marketing service agreement (the “Agreement”) with Resource Stock Digest (“ …